Literature DB >> 32926159

SUMO E3 ligase CBX4 regulates hTERT-mediated transcription of CDH1 and promotes breast cancer cell migration and invasion.

Sulagna Sanyal1,2, Payel Mondal2,3, Sabyasachi Sen2, Sumita Sengupta Bandyopadhyay1, Chandrima Das2,3.   

Abstract

hTERT, the catalytic component of the human telomerase enzyme, is regulated by post-translational modifications, like phosphorylation and ubiquitination by multiple proteins which remarkably affects the overall activity of the enzyme. Here we report that hTERT gets SUMOylated by SUMO1 and polycomb protein CBX4 acts as the SUMO E3 ligase of hTERT. hTERT SUMOylation positively regulates its telomerase activity which can be inhibited by SENP3-mediated deSUMOylation. Interestingly, we have established a new role of hTERT SUMOylation in the repression of E-cadherin gene expression and consequent triggering on the epithelial-mesenchymal-transition (EMT) program in breast cancer cells. We also observed that catalytically active CBX4, leads to retention of hTERT/ZEB1 complex onto E-cadherin promoter leading to its repression through hTERT-SUMOylation. Further through wound healing and invasion assays in breast cancer cells, we showed the tumor promoting ability of hTERT was significantly compromised upon overexpression of SUMO-defective mutant of hTERT. Thus our findings establish a new post-translational modification of hTERT which on one hand is involved in telomerase activity maintenance and on the other hand plays a crucial role in the regulation of gene expression thereby promoting migration and invasion of breast cancer cells.
© 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  E-cadherin; epithelial-to-mesenchymal transition; point mutation; polycomb repressive complex 1; sumoylation; telomerase

Year:  2020        PMID: 32926159     DOI: 10.1042/BCJ20200359

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  8 in total

1.  Chromobox 4 (CBX4) promotes tumor progression and stemness via activating CDC20 in gastric cancer.

Authors:  Wen Li; Honghui Chen; Zhenggen Wang; Jingjing Liu; Xinan Lei; Wen Chen
Journal:  J Gastrointest Oncol       Date:  2022-06

Review 2.  SUMOylation and NEDDylation in Primary and Metastatic Cancers to Bone.

Authors:  Marta Gomarasca; Giovanni Lombardi; Paola Maroni
Journal:  Front Cell Dev Biol       Date:  2022-04-06

3.  SLC6A8 Knockdown Suppresses the Invasion and Migration of Human Hepatocellular Carcinoma Huh-7 and Hep3B Cells.

Authors:  Lu Yuan; Xian Jian Wu; Wen Chuan Li; Chenyi Zhuo; ZuoMing Xu; Chuan Tan; RiHai Ma; JianChu Wang; Jian Pu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

4.  MicroRNA-133b Inhibits nTumor Cell Proliferation, Migration and Invasion by Targeting SUMO1 in Endometrial Carcinoma.

Authors:  Lingyun Liao; Yun Chen; Jieli Zhou; Jing Ye
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

5.  CBX4-dependent regulation of HDAC3 nuclear translocation reduces Bmp2-induced osteoblastic differentiation and calcification in adamantinomatous craniopharyngioma.

Authors:  Xiaorong Yan; Dezhi Kang; Yuanxiang Lin; Songtao Qi; Changzhen Jiang
Journal:  Cell Commun Signal       Date:  2022-01-03       Impact factor: 5.712

Review 6.  The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells.

Authors:  Xiaoxia Shi; Yixin Du; Shujing Li; Huijian Wu
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

Review 7.  Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.

Authors:  Nieves Lara-Ureña; Vahid Jafari; Mario García-Domínguez
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

8.  Human Polycomb Protein 2 (hPC2) as a Novel Independent Prognostic Marker in Nasopharyngeal Carcinoma.

Authors:  Mei Wu; Li Yang; Xiaojuan Hou; Ziyuan Wang; Jianqing Zhang
Journal:  Cancer Manag Res       Date:  2021-07-20       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.